Neuraxis Share Price

Neuraxis Share Price

AMEX: NRXS | Micro Cap | Healthcare
$4.27
-$0.27 (-5.95%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Neuraxis Stock Performance

Open
$4.27
Prev. Close
$4.54
Circuit Range
N/A
Day Range
$4.27 - $4.33
Year Range
$2.50 - $9.28
Volume
1,328
Average Traded
$4.28

Neuraxis Share Price Today

As of 21 November 2026, Neuraxis, Inc.'s share price is $4.27. The stock opened at $4.27, compared to its previous close of $4.54. During today's trading session, Neuraxis, Inc.'s share price traded between $4.27 and $4.33, with an average price of $4.30. Over the past 52 weeks, the stock has recorded a high of $9.28 and a low of $2.50. In terms of performance, Neuraxis, Inc.'s share price has declined by 41.27% over the last six months and is up 55.27% on a year-on-year basis.

Neuraxis Share Price Chart

Line chart of the Neuraxis price trend over the selected period. The price fell overall, ranging from 4.26 to 4.35, ending at 4.27.
$4.27$4.33
L
Show Current Price
H

Neuraxis Stock Fundamentals & Key Indicators

Market Cap
$38.79M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.91
Revenue (TTM)
$3.57B
Return On Equity (TTM)
-355.31%
Profit Margin
-241.46%
Debt to Equity
0.06
Quarterly Earnings Growth YoY
-254.74%

Neuraxis Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.97$1.61$1.93$2.03
Net Profit-$1.90-$1.95-$2.28-$6.74
Net Profit Margin-195.88%-121.12%-118.13%-332.02%
Income ChangeN/A-2.63%-16.92%-195.61%

Neuraxis Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$2.46$2.69$3.57
Net Profit-$14.63-$8.45-$8.62
Net Profit Margin-594.72%-314.13%-241.46%
Income ChangeN/A42.24%-2.01%

Neuraxis Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets0.670.490.27
Current Assets5.734.270.24
Total Assets6.44.760.51
Non Current Liabilities0.210.260.03
Current Liabilities2.792.431.89
Total Liabilities3.02.691.91
Shareholders' Equity3.42.07-1.4

Neuraxis Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-6.43-6.1-6.69
Investing-0.13-0.03-0.07
Financing7.839.746.59

About Neuraxis

Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Neuraxis Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.85
$4.33
-38.64%
Oct 2026
$7.44
$7.07
-4.40%
Sep 2026
$5.89
$7.39
+22.76%
Aug 2026
$6.54
$6.02
-4.44%
Jul 2026
$7.28
$6.30
-9.87%
Jun 2026
$7.17
$6.99
-3.85%
May 2026
$7.25
$7.27
-1.89%
Apr 2026
$7.33
$7.41
+1.93%
Mar 2026
$5.96
$7.27
+21.17%
Feb 2026
$4.38
$6.00
+38.89%
Jan 2026
$4.46
$4.32
-4.00%
Dec 2025
$2.77
$4.50
+63.64%

Neuraxis Share Price FAQs